Efficacy of External Nasal Nerve Block in Prevention of Postoperative Agitation Following Nasal Surgeries

December 23, 2017 updated by: Dr. Mohamed Ibrahim, Al Jedaani Hospital

Efficacy of External Nasal Nerve Block on Postoperative Agitation Following Nasal Surgeries Under General Anesthesia. Randomized, Controlled Trial

Emergence agitation following general anaesthesia may lead to serious complications like self-extubation or removal of catheters, which can lead to hypoxia, aspiration pneumonia, bleeding or reoperation. Nose surgery is associated with a higher incidence of emergence agitation. The investigators planned to evaluate the efficacy of external nasal nerve block in prevention of postoperative agitation following external nasal surgeries under general anesthesia(GA).

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Meccah
      • Jeddah, Meccah, Saudi Arabia, 21462/7500
        • Al Jedaani group of hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 110 adult patients of ASA physical status I and II,
  • Age 20-60 years,
  • Scheduled for elective external nasal surgeries in which nasal packing on each side was used postoperatively for 24 hours.

Exclusion Criteria:

  1. History of uncontrolled hypertension,
  2. Ischemic or valvular heart disease,
  3. Use of MAO inhibitors or adrenergic blocking drugs,
  4. Cognitive impairment,
  5. Patients taking antipsychotics,
  6. Renal insufficiency or liver dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Group I(control)
patients allocated for external nasal nerve block with saline adrenaline 1/200,000 (placebo)
Three single (midline injection) and 4 paired (bilateral injection) sites to block the external nasal sensation.
Active Comparator: Group II(block)
'External nasal nerve block by Xylocaine, adrenaline'
Three single (midline injection) and 4 paired (bilateral injection) sites to block the external nasal sensation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative agitation
Time Frame: Emergence is defined as the time interval from discontinuation of anesthesia to 5 min after extubation.
Assessment done using Richmond agitation- sedation scale (RASS)
Emergence is defined as the time interval from discontinuation of anesthesia to 5 min after extubation.
Quality of recovery
Time Frame: 24 hours postoperative
Quality of recovery
24 hours postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
dose of fentanyl
Time Frame: intraoperative period in minutes
Fentanyl boluses were given in response to changes in hemodynamics (more than 15% increases in MAP and HR than the baseline values taken after induction by 5 minutes)
intraoperative period in minutes
morphine dose in PACU
Time Frame: one hour in PACU
equivalent morphine dose in PACU (calculated using opioid:morphine equivalents of 100 µg i.v. fentanyl to 10 mg i.v. morphine; 75- 100 mg IV pethidine to 10 mg i.v. morphine
one hour in PACU
Nausea and vomiting in PACU
Time Frame: one hour in PACU
Four-point nausea and vomiting scale (0=no nausea; 1=mild nausea; 2=severe nausea requiring antiemetics; and 3=retching, vomiting, or both) was also evaluated
one hour in PACU
Extubation time
Time Frame: Up to 15 after discontinuation of anesthesia
Up to 15 after discontinuation of anesthesia
Surgical time
Time Frame: duration of surgery in minutes up to 3 hours
intraoperative
duration of surgery in minutes up to 3 hours
first verbal response time
Time Frame: up to 15 minutes
period from discontinuation of anesthesia 'time zero' to 1st verbal response in minutes
up to 15 minutes
complication of nasal block
Time Frame: From injection to 24 hours postoperative
including local anesthetic systemic toxicity, vascular injury, intravascular injection of local anesthetic, and local hematoma.
From injection to 24 hours postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2016

Primary Completion (Actual)

April 15, 2017

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

February 19, 2017

First Submitted That Met QC Criteria

March 1, 2017

First Posted (Actual)

March 3, 2017

Study Record Updates

Last Update Posted (Actual)

December 27, 2017

Last Update Submitted That Met QC Criteria

December 23, 2017

Last Verified

December 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Agitation States as Acute Reaction to Gross Stress

Clinical Trials on External nasal nerve block

3
Subscribe